Cite
HARVARD Citation
Werth, V. et al. (n.d.). SAT0512 Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated in an open label extension of trial jbt101-dm-001. Annals of the rheumatic diseases. pp. 1111-1112. [Online].